
Syngene has announced the launch of its new protein production platform, which will utilise a cell line and transposon-based technology …

BioAscent has announced that it has opened its new state-of-the-art protein production facility in an event chaired by Professor Michael …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

